Paired tumor and cfDNA in patients with HER2-mutant solid tumors treated with neratinib reveals convergence of multiple on-target resistance mechanisms: Results from the SUMMIT "Basket" Trial Meeting Abstract
| Authors: | Won, H. H.; Selcuklu, S. D.; Piha-Paul, S. A.; Saura, C.; Rodon, J.; Mayer, I. A.; Loi, S.; Shapiro, G. I.; Lu, J.; Brufsky, A.; Zimel, C.; Melcer, M.; Scaltriti, M.; Eli, L. D.; Cutler, R. E. Jr; Lalani, A. S.; Bryce, R. P.; Arteaga, C.; Meric-Bernstam, F.; Berger, M. F.; Solit, D. B.; Schram, A.; Hyman, D. M. |
| Abstract Title: | Paired tumor and cfDNA in patients with HER2-mutant solid tumors treated with neratinib reveals convergence of multiple on-target resistance mechanisms: Results from the SUMMIT "Basket" Trial |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129903029 |
| DOI: | 10.1158/1538-7445.Am2019-929 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 929 -- Source: Wos |
